Mounjaro is the brand name for tirzepatide, a prescription medicine used in the UK for type 2 diabetes and for weight management in eligible adults. It can support clinically meaningful weight loss for some people when combined with appropriate nutrition, physical activity and follow-up, but response and side effects vary.
It does not need to be combined automatically with a gastric balloon, gastric Botox or surgery, and it is not a quick-loss or guaranteed-result product.
What is tirzepatide and how does it work?
Tirzepatide acts at GIP and GLP-1 receptors. It can reduce appetite, increase fullness, slow digestion and affect blood-glucose regulation. For type 2 diabetes, it can help lower blood glucose; for weight management, it is prescribed within licensed criteria and a broader support plan.
“More powerful”, “superior” and fixed-percentage claims do not tell an individual what will happen. Trial averages, real-world response, tolerability and continued use are different questions.
Who can be prescribed Mounjaro for weight management?
A qualified prescriber should assess the current UK licence, BMI and weight-related health conditions, previous treatment, contraindications, medicines, pregnancy plans and the person’s ability to engage with monitoring. Private prescribing still requires a proper assessment; paying privately does not make the medicine appropriate for everyone.
NICE recommends tirzepatide for selected adults with obesity and weight-related conditions. NHS England is implementing access in phases, initially prioritising people with the highest clinical need. NHS eligibility, local service access and private prescribing are not identical.
How is Mounjaro used?
Mounjaro is supplied as a once-weekly injection in prescribed strengths. The prescriber decides the starting product, titration, review and stop plan using the authorised information and the patient’s response. This article does not provide a dose schedule.
- Use only the pen prescribed and supplied for you.
- Follow the prescriber and patient-information leaflet for injection technique, missed doses, storage and disposal.
- Do not extract medicine from a damaged pen or combine doses yourself.
- Do not share a pen, buy through social media or use another person’s prescription.
- Contact the prescriber if side effects prevent normal eating/drinking or if the product appears damaged or suspect.
Common side effects
Common effects can include nausea, diarrhoea, vomiting, constipation, abdominal discomfort, indigestion and reduced appetite. They may be more noticeable during initiation or dose changes, but severity and duration vary.
Vomiting and diarrhoea can cause dehydration and may affect kidney function or the absorption of other medicines. Seek advice if you cannot keep fluids down, pass much less urine, feel faint/confused or symptoms are severe or persistent.
Serious risks and precautions
- Acute pancreatitis: severe, persistent abdominal pain, sometimes spreading to the back and accompanied by vomiting, needs urgent assessment. The MHRA strengthened this warning in January 2026.
- Gallbladder problems: symptoms such as severe upper abdominal pain, fever or jaundice need clinical assessment.
- Low blood glucose: risk can rise when tirzepatide is used with insulin or certain diabetes medicines; an individual glucose and medicine plan is needed.
- Severe allergic reaction: breathing difficulty, facial/tongue swelling or collapse is an emergency.
- Delayed gastric emptying: can affect symptoms, oral medicines and anaesthesia planning.
Call 999 or attend A&E for life-threatening symptoms. Use NHS 111 or an urgent GP assessment for urgent concerns that are not immediately life-threatening. Bring the pen/packaging and a list of other medicines where possible.
Pregnancy and contraception
Tirzepatide is not recommended during pregnancy, when planning pregnancy or while breastfeeding according to current patient guidance. Discuss the medicine-specific stop period with the prescriber before trying to conceive.
Tirzepatide can reduce absorption of the oral contraceptive pill during initiation and dose increases. NHS guidance advises an additional method of contraception in specified circumstances. Ask the prescriber or pharmacist exactly what applies to you; do not rely on this summary alone.
Mounjaro and surgery or anaesthesia
Tell the surgeon, anaesthetist and pre-assessment team that you use tirzepatide, including the dose and last injection. Delayed stomach emptying can matter around sedation, fasting and aspiration risk. Do not stop or continue the medicine using a universal internet timetable; the appropriate clinician should give an individual plan.
Does Mounjaro need a gastric balloon?
No. The old page repeatedly claimed that Mounjaro alone was insufficient and that a balloon produced better long-term results. That was not an appropriate universal recommendation and has been removed.
A gastric balloon has separate indications, device/endoscopy risks and removal considerations. Combining it with tirzepatide could add adverse effects, dehydration risk, cost and complexity. A multidisciplinary clinician should explain the evidence and reason for any proposed combination rather than selling it as an automatic upgrade.
What happens if Mounjaro is stopped?
Weight regain can occur after treatment ends, but the amount varies. Before starting, discuss likely treatment duration, review and stop criteria, availability/cost, side effects and the support plan if the medicine is reduced or stopped. There is no shame in needing long-term obesity treatment, changing medicine or considering another appropriate option.
Mounjaro price and the IOC £1,800 package
No Mounjaro price or prescription is included in the IOC package. The stated £1,800 package is for a standard primary gastric sleeve pathway for a clinically eligible patient, including two hospital nights, one hotel night, interpreter support and Aylin Demir’s one-year dietetic follow-up pathway.
Tirzepatide requires separate UK-appropriate prescribing, supply and monitoring. The £1,800 price is not a medicine, balloon or combination-treatment price.
Frequently asked questions
Is Mounjaro licensed for weight loss in the UK?
Tirzepatide is licensed for weight management in eligible adults as well as for type 2 diabetes. The exact indication, criteria and product instructions should be confirmed by the prescriber.
Can I get Mounjaro from my GP?
NHS access is being phased and prioritised; local pathways and eligibility apply. Ask your GP or local NHS weight-management service, and use current NHS England information rather than assuming all eligible people can receive it immediately.
Is it safe to buy Mounjaro online?
Online prescribing can be legitimate only when there is a proper assessment and supply through a registered pharmacy. Avoid social-media sellers, beauty providers and sites that do not verify identity, health history and contraindications.
Which official sources should I read?
See the NHS tirzepatide guide, NHS England access information, NICE TA1026 and the MHRA GLP-1 safety guide.
